Avidity Biosciences Inc (RNA)
NASDAQ:RNA
US Market
Holding RNA?
Track your performance easily

Avidity Biosciences (RNA) Financial Statements

663 Followers

Avidity Biosciences Financial Overview

Avidity Biosciences's market cap is currently ―. The company's EPS TTM is $-2.952; its P/E ratio is -15.28; Avidity Biosciences is scheduled to report earnings on November 5, 2024, and the estimated EPS forecast is $-0.71. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 2.04M$ 3.54M$ 2.19M$ 2.82M$ 2.32M
Gross Profit$ 2.04M$ 3.54M$ 2.19M$ 2.82M$ 2.32M
EBIT$ -70.79M$ -77.19M$ -66.74M$ -52.36M$ -48.16M
EBITDA$ -66.31M$ -76.55M$ -66.13M$ -53.99M$ -49.77M
Net Income Common Stockholders$ -70.79M$ -68.86M$ -60.44M$ -52.36M$ -47.02M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 1.30B$ 915.87M$ 595.35M$ 542.58M$ 576.50M
Total Assets$ 1.35B$ 951.47M$ 628.55M$ 573.16M$ 610.78M
Total Debt$ 8.38M$ 9.15M$ 9.85M$ 10.58M$ 9.51M
Net Debt$ -1.29B$ -906.73M$ -585.50M$ -532.00M$ -566.99M
Total Liabilities$ 126.39M$ 120.58M$ 127.79M$ 55.70M$ 51.61M
Stockholders Equity$ 1.22B$ 830.92M$ 500.76M$ 517.47M$ 559.14M
Cash Flow-
Free Cash Flow$ -65.53M$ -71.30M$ 15.64M$ -37.69M$ -50.46M
Operating Cash Flow$ -65.00M$ -70.38M$ 16.50M$ -36.77M$ -49.84M
Investing Cash Flow$ -274.87M$ -32.75M$ 51.04M$ -31.48M$ 46.05M
Financing Cash Flow$ 446.72M$ 389.44M$ 31.89M$ 40.00K$ 38.97M
Currency in USD

Avidity Biosciences Earnings and Revenue History

Avidity Biosciences Debt to Assets

Avidity Biosciences Cash Flow

Avidity Biosciences Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis